Yes, we used to ride that bird flu hype. 2007? That was pretty crazy!
Look at 4D with a true partnership with Merck. Then look at their market cap. Hopefully there’s more we don’t know which explains Generex estimating suck a high value for NGIO before even getting study results from the smaller Ph 2 Open Label Proof of Concept.